This article reviews the current knowledge and experimental research about the mechanisms by which fatty acids and their derivatives control specific gene expression involved during carcinogenesis. Changes in dietary fatty acids, specifically the polyunsaturated fatty acids of the ω-3 and ω-6 families and some derived eicosanoids from lipoxygenases, cyclooxygenases, and cytochrome P-450, seem to control the activity of transcription factor families involved in cancer cell proliferation or cell death. Their regulation may be carried out either through direct binding to DNA as peroxisome proliferator-activated receptors or via modulation in an indirect manner of signaling pathway molecules (e.g., protein kinase C) and other transcription factors (nuclear factor kappa B and sterol regulatory element binding protein). Knowledge of the mechanisms by which fatty acids control specific gene expression may identify important risk factors for cancer and provide insight into the development of new therapeutic strategies for a better management of whole body lipid metabolism.
This article reviews the current knowledge and experimental research about the mechanisms by which n class="Chemical">fatty acids and their derivatives control specific gene expression involved during carcinogenesis. Changes in dietary fatty acids, specifically the polyunsaturated fatty acids of the ω-3 and ω-6 families and some derived eicosanoids from lipoxygenases, cyclooxygenases, and cytochrome P-450, seem to control the activity of transcription factor families involved in cancer cell proliferation or cell death. Their regulation may be carried out either through direct binding to DNA as peroxisome proliferator-activated receptors or via modulation in an indirect manner of signaling pathway molecules (e.g., protein kinase C) and other transcription factors (nuclear factor kappa B and sterol regulatory element binding protein). Knowledge of the mechanisms by which fatty acids control specific gene expression may identify important risk factors for cancer and provide insight into the development of new therapeutic strategies for a better management of whole body lipid metabolism.
Authors: M E Pasqualini; M A Berra; R O Calderón; D C Cremonezzi; C Giraudo; A R Eynard Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2005-04 Impact factor: 4.006
Authors: Mika Hilvo; Carsten Denkert; Laura Lehtinen; Berit Müller; Scarlet Brockmöller; Tuulikki Seppänen-Laakso; Jan Budczies; Elmar Bucher; Laxman Yetukuri; Sandra Castillo; Emilia Berg; Heli Nygren; Marko Sysi-Aho; Julian L Griffin; Oliver Fiehn; Sibylle Loibl; Christiane Richter-Ehrenstein; Cornelia Radke; Tuulia Hyötyläinen; Olli Kallioniemi; Kristiina Iljin; Matej Oresic Journal: Cancer Res Date: 2011-03-17 Impact factor: 12.701
Authors: Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein Journal: Proc Natl Acad Sci U S A Date: 2003-09-25 Impact factor: 11.205
Authors: Mara M Epstein; Julie L Kasperzyk; Lorelei A Mucci; Edward Giovannucci; Alkes Price; Alicja Wolk; Niclas Håkansson; Katja Fall; Swen-Olof Andersson; Ove Andrén Journal: Am J Epidemiol Date: 2012-07-10 Impact factor: 4.897
Authors: Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann Journal: Antioxid Redox Signal Date: 2013-04-15 Impact factor: 8.401
Authors: Andrea Comba; Luciana L Almada; Ezequiel J Tolosa; Eriko Iguchi; David L Marks; Marianela Vara Messler; Renata Silva; Maite G Fernandez-Barrena; Elisa Enriquez-Hesles; Anne L Vrabel; Bruno Botta; Lucia Di Marcotulio; Volker Ellenrieder; Aldo R Eynard; Maria E Pasqualini; Martin E Fernandez-Zapico Journal: J Biol Chem Date: 2015-11-24 Impact factor: 5.157